CN103735802A - Traditional Chinese medicine composition for treating hyperplasia of mammary glands - Google Patents
Traditional Chinese medicine composition for treating hyperplasia of mammary glands Download PDFInfo
- Publication number
- CN103735802A CN103735802A CN201310731368.0A CN201310731368A CN103735802A CN 103735802 A CN103735802 A CN 103735802A CN 201310731368 A CN201310731368 A CN 201310731368A CN 103735802 A CN103735802 A CN 103735802A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- traditional chinese
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating hyperplasia of mammary glands. The composition comprises the following components in parts by weight: 40-50 parts of fistular onion stalk, 40-50 parts of fructus forsythiae, 40-50 parts of dandelion, 40-50 parts of white manyleaf paris rhizome, 40-50 parts of Chinese lobelia, 20-30 parts of ligusticum wallichii, 20-30 parts of corydalis tuber, 20-30 parts of agilawood, 20-30 parts of the root of three-nerved spicebush, 5-15 parts of vinegar fried radix bupleuri, 5-15 parts of fingered citron, 5-15 parts of mint, and 5 parts of liquorice. The traditional Chinese medicine composition for treating hyperplasia of mammary glands is prepared according to traditional Chinese medicine theories, comprises various traditional Chinese medicines so as to have maximum pharmaceutical effects, has small toxic and side effects, has low cost and can address both symptoms and root causes.
Description
Technical field
The present invention relates to field of traditional Chinese, particularly a kind of Chinese medicine composition for the treatment of cyclomastopathy.
Background technology
Cyclomastopathy refers to breast epithelium and proliferation of fibrous tissue, mammary gland tissue conduit and newborn lobule degeneration structurally and the growth of carrying out property connective tissue, and its pathogenic factor is mainly due to endocrine hormone imbalance.Clinical manifestation mainly contains: 1. mastalgia is often distending pain or twinge, can involve one or both sides breast, and heavy common with a lateral deviation, pain severe patient can not be touched, and even affects daily life and work.Pain be take lump in breast place as main, also can be to Ipsilateral axillary fossa, the breast side of body or the radiation of shoulder back; Some shows as sore nipples or itches.Mastalgia Chang Yuyue premenstrual a couple of days occurs or increases the weight of, and after passing through, pain obviously alleviates or disappears; Pain also can fluctuate with emotion changes.This pain relevant with menstrual cycle and emotion changes is the main feature of cyclomastopathy clinical manifestation.2. lump in breast, lump can be sent out in one-sided or bilateral breast, single or multiple, is apt to occur in the outside upper quadrant of breast, is also found in other quadrants.Lump shape has sheet bulk, nodositas, streak, graininess etc., and the sheet of wherein take is block as common.Lump border is not obvious, and quality is medium or slightly firmly tough, movable good, without adhesion, often has tenderness with surrounding tissue.Lump is not of uniform size, and little person is as large as foxtail millet grain, and large person can exceed 3~4cm.Lump in breast also has the feature changing with menstrual cycle, and a month premenstrual lump increases hardening, and after menstrual onset, lump dwindles deliquescing.3. nipple discharge, can there are nipple discharge in small number of patients, be spontaneous discharge, also have few person push nipple have as seen courageous and upright discharge or milky to overflow body overflows, olive drab(O.D) or brown serosity discharge.4. menoxenia, this patient can doublely see before and after menstruation irregularly, amount less or color light, can accompany dysmenorrhea.5. feelings will changes, the smooth or susceptible to lose temper due to restlessness of the normal emotion will of patient, whenever angry, psychentonia or tired postemphasis.
Summary of the invention
For the defect existing in prior art, the object of the present invention is to provide a kind of Chinese medicine composition for the treatment of cyclomastopathy.
Technical scheme of the present invention is as follows:
Treat a Chinese medicine composition for cyclomastopathy, by following component, according to weight fraction, formed:
Bulbus Allii Fistulosi 40-50 part, Fructus Forsythiae 40-50 part, Herba Taraxaci 40-50 part, Rhizoma Paridis 40-50 part, Herba Lobeliae Chinensis 40-50 part, Rhizoma Chuanxiong 20-30 part, Rhizoma Corydalis 20-30 part, Lignum Aquilariae Resinatum 20-30 part, Radix Linderae 20-30 part, vinegar Radix Bupleuri Chinensis (parched) 5-15 part, Fructus Citri Sarcodactylis 5-15 part, Herba Menthae 5-15 part, 5 parts, Radix Glycyrrhizae.
On the basis of such scheme, a kind of Chinese medicine composition for the treatment of cyclomastopathy, is comprised of according to weight fraction following component:
45 parts of Bulbus Allii Fistulosi, 45 parts of Fructus Forsythiaes, 45 parts of Herba Taraxacis, 45 parts of Rhizoma Paridiss, 45 parts of Herba Lobeliae Chinensis, 25 parts of Rhizoma Chuanxiong, 25 parts of Rhizoma Corydalis, 25 parts of Lignum Aquilariae Resinatum, 25 parts of the Radixs Linderae, 10 parts of vinegar Radix Bupleuri Chinensis (parched), 10 parts of Fructus Citri Sarcodactylis, 10 parts of Herba Menthaes, 5 parts, Radix Glycyrrhizae.
Chinese medicine composition of the present invention, reasonable recipe, Bulbus Allii Fistulosi dispelling cold and activating YANG, detoxicating and resolving stagnation of pathogens in prescription, Fructus Forsythiae heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation, Herba Taraxaci heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation, Rhizoma Paridis heat-clearing and toxic substances removing, reducing swelling and alleviating pain, Herba Lobeliae Chinensis heat-clearing and toxic substances removing, inducing diuresis to remove edema, five medicines are played heat-clearing and toxic substances removing, mass dissipating and swelling eliminating effect altogether, are monarch drug; Rhizoma Chuanxiong, Rhizoma Corydalis blood-activating and qi-promoting, Lignum Aquilariae Resinatum, Radix Linderae promoting the circulation of QI to relieve pain, four medicines are ministerial drug altogether; Vinegar Radix Bupleuri Chinensis (parched) dispersing the stagnated live-QI to relieve the stagnation of QI, elevate a turnable ladder yang-energy, Fructus Citri Sarcodactylis, Herba Menthae depressed liver-energy dispersing and QI regulating, three medicines are adjuvant drug altogether; Radix Glycyrrhizae invigorating the spleen and replenishing QI, the mitigation property of medicine are for making medicine.
The Chinese medicine composition for the treatment of cyclomastopathy of the present invention, formulated according to theory of Chinese medical science, each taste Chinese medicine composition, brings into play maximum drug effect, Chinese medicine preparation, toxic and side effects is little, and cost is low, treating both the principal and secondary aspects of a disease.
The specific embodiment
Embodiment 1
Treat a Chinese medicine composition for cyclomastopathy, by following component, according to weight fraction, form (every part of 1g):
40 parts of Bulbus Allii Fistulosi, 40 parts of Fructus Forsythiaes, 40 parts of Herba Taraxacis, 40 parts of Rhizoma Paridiss, 40 parts of Herba Lobeliae Chinensis, 20 parts of Rhizoma Chuanxiong, 20 parts of Rhizoma Corydalis, 20 parts of Lignum Aquilariae Resinatum, 20 parts of the Radixs Linderae, 5 parts of vinegar Radix Bupleuri Chinensis (parched), 5 parts of Fructus Citri Sarcodactylis, 5 parts of Herba Menthaes, 5 parts, Radix Glycyrrhizae.
Embodiment 2
Treat a Chinese medicine composition for cyclomastopathy, by following component, according to weight fraction, form (every part of 1g):
45 parts of Bulbus Allii Fistulosi, 45 parts of Fructus Forsythiaes, 45 parts of Herba Taraxacis, 45 parts of Rhizoma Paridiss, 45 parts of Herba Lobeliae Chinensis, 25 parts of Rhizoma Chuanxiong, 25 parts of Rhizoma Corydalis, 25 parts of Lignum Aquilariae Resinatum, 25 parts of the Radixs Linderae, 10 parts of vinegar Radix Bupleuri Chinensis (parched), 10 parts of Fructus Citri Sarcodactylis, 10 parts of Herba Menthaes, 5 parts, Radix Glycyrrhizae.
Embodiment 3
Treat a Chinese medicine composition for cyclomastopathy, by following component, according to weight fraction, form (every part of 1g):
50 parts of Bulbus Allii Fistulosi, 50 parts of Fructus Forsythiaes, 50 parts of Herba Taraxacis, 50 parts of Rhizoma Paridiss, 50 parts of Herba Lobeliae Chinensis, 30 parts of Rhizoma Chuanxiong, 30 parts of Rhizoma Corydalis, 30 parts of Lignum Aquilariae Resinatum, 30 parts of the Radixs Linderae, 15 parts of vinegar Radix Bupleuri Chinensis (parched), 15 parts of Fructus Citri Sarcodactylis, 15 parts of Herba Menthaes, 5 parts, Radix Glycyrrhizae.
Experimental example:
Select 30 routine cyclomastopathy patients, wherein one-sided breast morbidity and each 15 examples of bilateral breast morbidity.Through breast molybdenum target, take the photograph sheet inspection and get rid of after breast tumor, be diagnosed as sick 13 examples of mammary gland capsule cyclomastopathy, cyclomastopathy disease 8 examples, mastalgia 9 examples.
The Chinese medicine composition of Therapeutic Method: embodiment 2 routinely technique is made decoction, 1 dose of every day, every day 2 times, within 2 months, is 1 course for the treatment of, treats continuously 2 courses for the treatment of.
Criterion of therapeutical effect
< < disease of tcm Standardization of diagnosis and curative effect > > with reference to State Administration of Traditional Chinese Medicine's issue formulates.
1. recovery from illness: distending pain of the breast and lump disappear, takes the photograph sheet inspection in conjunction with breast molybdenum target and confirms the disappearance of cyclomastopathy sign.Within after drug withdrawal 3 months, do not recur.
2. effective: distending pain of the breast disappears, and lump maximum gauge dwindles more than 50%, breast molybdenum target takes the photograph that sheet inspection confirms that cyclomastopathy tuberosity dwindles or hypertrophy body of gland density alleviates with clinical and conforms to.
3. effective: distending pain of the breast alleviates, physical palpation lump dwindles, but not as good as 50%, breast molybdenum target is taken the photograph sheet inspection and confirmed that cyclomastopathy takes a turn for the better, and conforms to palpation substantially with clinical symptoms.
4. invalid: distending pain of the breast and lump are not improved with comparing before treatment, and breast molybdenum target is taken the photograph sheet inspection and is confirmed.
Through there being the observation of two courses for the treatment of, 30 routine patients all meet the standard of recovery from illness, and during whole treatment, do not observe obvious untoward reaction.
Claims (2)
1. treat a Chinese medicine composition for cyclomastopathy, it is characterized in that being formed according to weight fraction by following component:
Bulbus Allii Fistulosi 40-50 part, Fructus Forsythiae 40-50 part, Herba Taraxaci 40-50 part, Rhizoma Paridis 40-50 part, Herba Lobeliae Chinensis 40-50 part, Rhizoma Chuanxiong 20-30 part, Rhizoma Corydalis 20-30 part, Lignum Aquilariae Resinatum 20-30 part, Radix Linderae 20-30 part, vinegar Radix Bupleuri Chinensis (parched) 5-15 part, Fructus Citri Sarcodactylis 5-15 part, Herba Menthae 5-15 part, 5 parts, Radix Glycyrrhizae.
2. the Chinese medicine composition for the treatment of cyclomastopathy according to claim 1, is characterized in that being comprised of according to weight fraction following component:
45 parts of Bulbus Allii Fistulosi, 45 parts of Fructus Forsythiaes, 45 parts of Herba Taraxacis, 45 parts of Rhizoma Paridiss, 45 parts of Herba Lobeliae Chinensis, 25 parts of Rhizoma Chuanxiong, 25 parts of Rhizoma Corydalis, 25 parts of Lignum Aquilariae Resinatum, 25 parts of the Radixs Linderae, 10 parts of vinegar Radix Bupleuri Chinensis (parched), 10 parts of Fructus Citri Sarcodactylis, 10 parts of Herba Menthaes, 5 parts, Radix Glycyrrhizae.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310731368.0A CN103735802A (en) | 2013-12-26 | 2013-12-26 | Traditional Chinese medicine composition for treating hyperplasia of mammary glands |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310731368.0A CN103735802A (en) | 2013-12-26 | 2013-12-26 | Traditional Chinese medicine composition for treating hyperplasia of mammary glands |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103735802A true CN103735802A (en) | 2014-04-23 |
Family
ID=50492918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310731368.0A Pending CN103735802A (en) | 2013-12-26 | 2013-12-26 | Traditional Chinese medicine composition for treating hyperplasia of mammary glands |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103735802A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103721012A (en) * | 2014-01-02 | 2014-04-16 | 张永雷 | Traditional Chinese medicine composition for treating hyperplasia of mammary glands |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1242209A (en) * | 1998-07-20 | 2000-01-26 | 郑相松 | Traditonal Chinese medicine soft extract for anticancer and relieving pain |
CN101254265A (en) * | 2008-04-21 | 2008-09-03 | 北京中科仁和科技有限公司 | Chinese medicinal composition for curing gland hyperplasia and method of preparing the same |
CN101966320A (en) * | 2010-07-13 | 2011-02-09 | 泰一和浦(北京)中医药研究院有限公司 | Chinese medicinal composition for treating proliferation of mammary gland and preparation method thereof |
-
2013
- 2013-12-26 CN CN201310731368.0A patent/CN103735802A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1242209A (en) * | 1998-07-20 | 2000-01-26 | 郑相松 | Traditonal Chinese medicine soft extract for anticancer and relieving pain |
CN101254265A (en) * | 2008-04-21 | 2008-09-03 | 北京中科仁和科技有限公司 | Chinese medicinal composition for curing gland hyperplasia and method of preparing the same |
CN101966320A (en) * | 2010-07-13 | 2011-02-09 | 泰一和浦(北京)中医药研究院有限公司 | Chinese medicinal composition for treating proliferation of mammary gland and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
薛秀安: "乳复康治疗乳腺增生病80例", 《湖北中医杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103721012A (en) * | 2014-01-02 | 2014-04-16 | 张永雷 | Traditional Chinese medicine composition for treating hyperplasia of mammary glands |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104043049A (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
CN102886031A (en) | Traditional Chinese medicine for treating hyperplasia of mammary glands and preparation method of traditional Chinese medicine | |
CN103055266A (en) | Chinese medicinal herb composition for treating liver cancer and preparation method thereof | |
CN105434972A (en) | Traditional Chinese medicine composition for treating breast hyperplasia | |
CN103656530B (en) | A kind of Chinese medicine composition for the treatment of cyclomastopathy | |
CN104288328A (en) | Traditional Chinese medicinal composition for treating herpes zoster and preparation method thereof | |
CN103735802A (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
CN103948860B (en) | A kind of Chinese medicine composition treating cyclomastopathy and preparation method thereof | |
CN103393825A (en) | Traditional Chinese medicine for treating catatonic headache and preparation method thereof | |
CN103127465B (en) | Chinese medicament for treating mammary gland hyperplasia | |
CN103191369B (en) | Chinese medicinal composition for treating mammary gland hyperplasia | |
CN105213870A (en) | A kind of Chinese medicine composition for the treatment of chronic bronchitis | |
CN101564522A (en) | Chinese medicament for treating intercostal nerve pain and preparation method thereof | |
CN103721012A (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
CN101396534B (en) | Traditional Chinese medicine for treating lobular hyperplasia of mammary gland | |
CN104162052A (en) | Preparation method of traditional Chinese medicine composition for treating psoriasis | |
CN103330792B (en) | Traditional Chinese medicine lotion for treating tinea pedes | |
CN102018802A (en) | Traditional Chinese medicine capsule used for treating mammitis | |
CN103623348A (en) | Traditional Chinese medicine composition for treating stomach cancer | |
CN105663850A (en) | Traditional Chinese medicine composition for treating oral ulcer | |
CN105641222A (en) | Traditional Chinese medicine for treating gastric cancer | |
CN106924646A (en) | A kind of plaster for treating the proliferation of mammary gland | |
CN104758784A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
CN105362851A (en) | Method for preparing traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
CN103055213B (en) | A kind of Chinese medicine decoction of wart of dispelling |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140423 |